TidalSense
It develops an AI-enabled respiratory diagnostic device intended to help identify asthma and other breathing conditions.
Overview
TidalSense builds a medical device for respiratory diagnostics, with its latest funding tied to founder Ameera Patel’s experience being unable to get her own asthma diagnosed. The company targets healthcare providers and patients needing faster, more accessible assessment of breathing conditions. Its differentiation centers on combining a dedicated diagnostic device with AI-driven analysis for asthma detection. The company has raised $19 million in an undisclosed round, positioning it as an AI healthcare company focused on respiratory medicine.
Funding History
Ameera Patel couldn’t get diagnosed with her own asthma. So she built this device and raised $19M
Frequently Asked Questions
- How much funding does AI Funding track for TidalSense?
- AI Funding tracks $19M for TidalSense across 1 funding round in this database.
- What does TidalSense do?
- TidalSense builds a medical device for respiratory diagnostics, with its latest funding tied to founder Ameera Patel’s experience being unable to get her own asthma diagnosed. The company targets healthcare providers and patients needing faster, more accessible assessment of breathing conditions. Its differentiation centers on combining a dedicated diagnostic device with AI-driven analysis for asthma detection. The company has raised $19 million in an undisclosed round, positioning it as an AI healthcare company focused on respiratory medicine.
- Where is TidalSense headquartered?
- TidalSense is headquartered in Cambridge, United Kingdom.
Related Insights
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $25.9 billion raised across 94 deals, with 14 mega-rounds capturing 79.8% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.
A deep comparison of Science Corp.'s neurotech-driven brain-computer interfaces and Nscale's AI cloud infrastructure, examining how $230M and $2B in recent funding fuel fundamentally different visions of artificial intelligence.